Dr. Ghadah Ghourab
Consultant in Reproductive Medicine and IVF

Short Curriculum Vitae
Completed her residency training in Obstetrics and Gynaecology at Security Forces hospital in 2009.
Obtained the MRCOG, Arab Board and Saudi Board certification in Obstetrics and Gynaecology in 2009.
In 2012, she completed a two-year fellowship training in Reproductive Endocrinology and Infertility, at King Faisal Specialist Hospital and Research center.
She joined IVF Hammersmith, Imperial NHS Trust, London UK, in August 2014 where she worked for one year as a clinical fellow in Reproductive Medicine.
Her special interests are Fertility preservation and Recurrent Miscarriage.

Session - 4
15:00 PM – 15:20 PM
Making of OncoFertility Consortium Saudi Arabia; challenges and breakthroughs.  [Dr. Ghadah Ghourab]

The oncofertility consortium Saudi Arabia (OCSA) was established in March 2018 with the vision of providing world class fertility cryopreservation services to cancer patients in Saudi Arabia.
The oncofertility consortium is an international multi-institutional group that assesses the impact of cancer and its treatment on reproductive health. It was founded by Dr. Teresa Woodruff in 2007 with a mission of expanding fertility options for cancer survivors.
In February 2018, Dr Teresa Woodruff visited Riyadh, Saudi Arabia and a meeting was held with the founding members of OCSA with the aim of developing a framework for Saudi Arabia to become a member of the International Oncofertility Consortium. This ultimately paved the way for the establishment of OCSA which has over 90 members today from all over the Kingdom of Saudi Arabia.
In the space of a few months OCSA has established all the guidelines for fertility preservation in Saudi Arabia as well as taken large strides in the process of legalizing fertility preservation in a country where this has long been illegal.
Once legalized , and with the standard operating procedures and guidelines as well as specialized centers already in place, fertility preservation can finally be offered to the thousands of cancer patients in Saudi Arabia who were previously faced with the bleak prospect of losing all hope of parenthood after cancer treatment.

Ask A Question